Vera Therapeutics, Inc. (VERA)
USD 41.36
(-5.81%)
USD 41.36
(-5.81%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|
| Revenue | 1.86 Million | - | - | - | - |
| Cost of Revenue | - | -846 Thousand | 176 Thousand | 251 Thousand | 509 Thousand |
| Gross Profit | 1.86 Million | 846 Thousand | -176 Thousand | -251 Thousand | -509 Thousand |
| Operating Expenses | 102.01 Million | 90.9 Million | 34.4 Million | 49.24 Million | 11.7 Million |
| Selling, General and Administrative Expenses | 23.78 Million | 21.91 Million | 11.91 Million | 4.03 Million | 4.41 Million |
| Research and Development Expenses | 78.22 Million | 68.99 Million | 22.48 Million | 45.2 Million | 7.29 Million |
| Other Expenses | - | 1.84 Million | 1.79 Million | -1.07 Million | - |
| Cost and Expenses | 102.01 Million | 90.9 Million | 34.4 Million | 49.24 Million | 11.7 Million |
| Operating Income | -102.01 Million | -90.9 Million | -34.4 Million | -52.24 Million | -11.96 Million |
| Interest Expense | - | 992 Thousand | 20 Thousand | 166 Thousand | 51 Thousand |
| Income Tax Expense | 1000.00 | 1000.00 | 1000.00 | 1000.00 | 1000.00 |
| Earnings before Tax | -95.98 Million | -89.05 Million | -32.6 Million | -53.41 Million | -11.85 Million |
| Net Income | -95.99 Million | -89.05 Million | -32.6 Million | -53.41 Million | -11.85 Million |
| Earnings Per Share Basic | -2.25 | -3.35 | -1.53 | -14.40 | -3.46 |
| Earnings Per Share Diluted | -2.25 | -3.35 | -1.53 | -14.40 | -3.46 |
| Weighted Average Shares Outstanding | 42.7 Million | 26.57 Million | 21.27 Million | 3.7 Million | 3.42 Million |
| Weighted Average Shares Outstanding (Diluted) | 42.7 Million | 26.57 Million | 21.27 Million | 3.7 Million | 3.42 Million |
| Gross Margin | 1.00 | - | - | - | - |
| EBIT Margin | -54.79 | - | - | - | - |
| Profit Margin | -51.55 | - | - | - | - |
| EBITDA | -102.01 Million | -90.9 Million | -34.22 Million | -52.99 Million | -11.19 Million |
| Earnings Before Tax Margin | -54.79 | - | - | - | - |
| Breakdown | 2024 Q2 | 2024 Q1 | 2023 FY | 2023 Q4 | 2023 Q3 | 2023 Q2 |
|---|---|---|---|---|---|---|
| Revenue | - | - | - | - | - | - |
| Cost of Revenue | - | -952 Thousand | -1.86 Million | -635 Thousand | - | - |
| Gross Profit | - | 952 Thousand | 1.86 Million | 635 Thousand | - | - |
| Operating Expenses | 37.34 Million | 32.06 Million | 103.87 Million | 27.66 Million | 21.75 Million | 21.97 Million |
| Selling, General and Administrative Expenses | 8.03 Million | 7.39 Million | - | 5.71 Million | 5.65 Million | 5.73 Million |
| Research and Development Expenses | 29.31 Million | 24.66 Million | - | 21.95 Million | 16.1 Million | 16.23 Million |
| Other Expenses | 450 Thousand | 453 Thousand | - | 472 Thousand | 1.65 Million | 511 Thousand |
| Cost and Expenses | 37.34 Million | 31.11 Million | 102.01 Million | 27.02 Million | 21.75 Million | 21.97 Million |
| Operating Income | -37.34 Million | -31.11 Million | -102.01 Million | -27.02 Million | -21.75 Million | -21.97 Million |
| Interest Expense | 1.91 Million | 1.9 Million | -3.78 Million | 1.05 Million | -943 Thousand | 914 Thousand |
| Income Tax Expense | - | -995.27 Thousand | 1000.00 | 1000.00 | 1.44 Million | 2.39 Million |
| Earnings before Tax | -33.7 Million | -28.38 Million | -95.98 Million | -25.65 Million | -20.1 Million | -20.16 Million |
| Net Income | -33.7 Million | -28.38 Million | -95.99 Million | -25.65 Million | -20.1 Million | -20.16 Million |
| Earnings Per Share Basic | -0.62 | -0.56 | - | -0.58 | -0.45 | -0.46 |
| Earnings Per Share Diluted | -0.62 | -0.56 | - | -0.58 | -0.45 | -0.46 |
| Weighted Average Shares Outstanding | 54.72 Million | 50.97 Million | 42.7 Million | 44.45 Million | 44.36 Million | 44.26 Million |
| Weighted Average Shares Outstanding (Diluted) | 54.72 Million | 50.97 Million | 42.7 Million | 44.45 Million | 44.36 Million | 44.26 Million |
| Gross Margin | - | - | - | - | - | - |
| EBIT Margin | - | - | - | - | - | - |
| Profit Margin | - | - | - | - | - | - |
| EBITDA | -35.84 Million | -32.06 Million | - | -27.66 Million | -21.75 Million | -19.22 Million |
| Earnings Before Tax Margin | - | - | - | - | - | - |
2303
VEL
200570
2362
3526
BSSP